Boston, MA, United States of America

Balaram Ghosh


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Hyderabad, IN (2018 - 2022)
  • Boston, MA (US) (2018 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Balaram Ghosh: Innovator in Histone Deacetylase Inhibitors

Introduction

Balaram Ghosh is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of histone deacetylase inhibitors. With a total of five patents to his name, Ghosh's work has the potential to impact the treatment of various hematological disorders.

Latest Patents

Ghosh's latest patents include innovative compounds that serve as photoswitchable inhibitors of histone deacetylases. This invention relates to methods of using these inhibitors to regulate gene expression. Another notable patent focuses on compounds that inhibit histone deacetylase activity, along with methods for synthesizing these compounds. These inventions also encompass pharmaceutical compositions that can be used to treat and prevent hematological cell proliferative disorders, such as multiple myeloma.

Career Highlights

Throughout his career, Balaram Ghosh has worked with esteemed organizations, including The General Hospital Corporation and Dana-Farber Cancer Institute Inc. His research has been pivotal in advancing the understanding of histone deacetylases and their role in cancer treatment.

Collaborations

Ghosh has collaborated with notable colleagues in his field, including Ralph Mazitschek and Stephen J. Haggarty. These partnerships have further enriched his research and contributed to the development of innovative therapeutic strategies.

Conclusion

Balaram Ghosh's contributions to the field of histone deacetylase inhibitors highlight his role as a key innovator in biochemistry. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…